Your Artstor image groups were copied to Workspace. The Artstor website will be retired on Aug 1st. Journal of Transport and Land Use Vol. 10, No. 1, 2017 The Propensity to Cycle Tool: An open so ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN DIEGO -- In a propensity-matched comparison of two CAR T-cell therapies, ciltacabtagene autoleucel (cilta-cel ...

For others, it may be a bit more quotidian. And if we want low-propensity voters to begin building the habit, we have to ...

In a propensity-matched comparison of two CAR T-cell therapies, ciltacabtagene autoleucel (cilta-cel, Carvykti) demonstrated better efficacy than idecabtagene vicleucel (ide-cel, Abecma) for ...